Home   »  TRADE TOPICS  »  Prescription Drugs  »  Trans Pacific Partnership

Letter to President Obama from VT Governor Peter Shumlin on Pharmaceuticals and the Trans Pacific Partnership

June 1st, 2011

Dear Mr. President:

As the Office of the United States Trade Representative prepares its negotiating text for the Trans Pacific Partnership Agreement (TPP), the pharmaceutical industry and others are seeking the inclusion of a pharmaceuticals chapter that would set disciplines on pricing and reimbursement programs abroad. After reading the letter sent to you last week by 28 Senators calling on you to maintain strong IP rights in the Trans-Pacific Partnership Trade Agreement, I want to respond with examples that illustrate how some of the requests made in that letter may impact states. Since trade agreements are reciprocal in nature, it is important to consider that millions of Americans rely on programs such as Medicaid, the 340B pricing program, and Medicare Part B that engage in the same types of pricing and reimbursement policies that the pharmaceutical industry and signatories to the Senate letter of May 17th oppose.

Unless otherwise expressly stated, all original material of whatever nature created by the Forum on Democracy & Trade website is licensed under a Creative Commons License. Privacy Statement | Sitemap